Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore

被引:8
|
作者
Hackman, Jada [1 ]
Falade-Nwulia, Oluwaseun [2 ]
Patel, Eshan U. [3 ]
Mehta, Shruti H. [2 ]
Kirk, Gregory D. [2 ,4 ]
Astemborski, Jacquie [2 ]
Ray, Stuart C. [4 ]
Thomas, David L. [2 ,4 ]
Laeyendecker, Oliver [1 ,2 ,4 ]
机构
[1] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
Hepatitis C virus; 1CE; Phylogenetic; Molecular epidemiology; PWID; Injection drug use; HUMAN-IMMUNODEFICIENCY-VIRUS; RISK-FACTORS; HCV INFECTION; NEW-YORK; TRANSMISSION; USERS; HIV; PREVALENCE; VANCOUVER; NETWORK;
D O I
10.1016/j.meegid.2019.104078
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study examines correlates of hepatitis C virus (HCV) genetic clustering among community-recruited people who inject drugs enrolled in the AIDS Linked to the IntraVenous Experience cohort in Baltimore between 1988 and 1989. HCV RNA was extracted and the core/envelope-1 region was sequenced. Clusters were identified from maximum likelihood trees with 1000 bootstrap replicates using a 70% aLRT and a 4% genetic-distance threshold in Cluster Picker. Overall, 46% of participants were in a cluster, including 122 genotype-1a and 36 genotype-1b clusters with an average of 2-3 genetically linked HCV infections. The largest cluster consists of 9 participants. In univariable analysis, black race (PR= 1.66 [95% CI: 1.12-2.45]), age < 35 years (PR= 1.18 [95% CI: 1.02-1.37]), and injection drug use of cocaine alone (PR= 1.30 [95% CI: 1.02-1.65]) were significantly associated with being in a cluster. Conversely, a history of medication-associated treatment (MAT) was negatively associated with being in a cluster (PR= 0.82 [95% CI: 0.71-0.95]). In multivariable analysis, black race (APR = 1.62 [95% CI: 1.11-2.38]) remained independently associated being in a cluster while MAT (APR = 0.85 [95% CI: 0.74-0.99]) remained negatively associated with clustering. Our findings suggest strong locally-propagated transmission networks during the early epidemic that was driven by younger PWID. In light of the current opioid epidemic in the US, these findings suggest an urgent need for preventive interventions to mitigate the growth of large HCV transmission networks.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] HEPATITIS C TREATMENT, REINFECTION AND ELIMINATION AMONG PEOPLE WHO INJECT DRUGS
    Hajarizadeh, Behzad
    DRUG AND ALCOHOL REVIEW, 2019, 38 : S9 - S9
  • [22] Dynamic modeling of hepatitis C transmission among people who inject drugs
    Stocks, Theresa
    Martin, Leah J.
    Kuhlmann-Berenzon, Sharon
    Britton, Tom
    EPIDEMICS, 2020, 30
  • [23] PREVALENCE AND PREDICTORS OF HEPATITIS C AMONG YOUNG PEOPLE WHO INJECT DRUGS
    Papanastasiou, Cerissa
    Dietze, Paul
    Higgs, Peter
    Jenkinson, Rebecca
    DRUG AND ALCOHOL REVIEW, 2011, 30 : 71 - 71
  • [24] Hepatitis C virus risk among young people who inject drugs
    Mateu-Gelabert, Pedro
    Sabounchi, Nasim S.
    Guarino, Honoria
    Ciervo, Courtney
    Joseph, Kellie
    Eckhardt, Benjamin J.
    Fong, Chunki
    Kapadia, Shashi N.
    Huang, Terry T. K.
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [25] Results of hepatitis C treatment program among people who inject drugs
    Filippovych, S.
    Burgay, O.
    Pavlyiuk, I.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S737 - S737
  • [26] Enhancing engagement in hepatitis C care among people who inject drugs
    Marshall, Alison D.
    Madden, Annie
    Treloar, Carla
    ADDICTION, 2019, 114 (12) : 2104 - 2106
  • [27] Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India
    Clipman, Steven J.
    Mehta, Shruti H.
    Rodgers, Mary A.
    Duggal, Priya
    Srikrishnan, Aylur K.
    Saravanan, Shanmugam
    Balakrishnan, Pachamuthu
    Vasudevan, Canjeevaran K.
    Ray, Stuart C.
    Kumar, Muniratnam S.
    Quinn, Thomas C.
    Cloherty, Gavin A.
    Lucas, Gregory M.
    Solomon, Sunil S.
    HEPATOLOGY, 2021, 74 (04) : 1782 - 1794
  • [28] Mitochondrial Genotoxicity of Hepatitis C Treatment among People Who Inject Drugs
    Durand, Melusine
    Nagot, Nicolas
    Nhu, Quynh Bach Thi
    Vallo, Roselyne
    Thuy, Linh Le Thi
    Duong, Huong Thi
    Thanh, Binh Nguyen
    Rapoud, Delphine
    Quillet, Catherine
    Tran, Hong Thi
    Michel, Laurent
    Tuyet, Thanh Nham Thi
    Hai, Oanh Khuat Thi
    Hai, Vinh Vu
    Feelemyer, Jonathan
    Vande Perre, Philippe
    Jarlais, Don Des
    Minh, Khue Pham
    Laureillard, Didier
    Moles, Jean-Pierre
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [29] Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore
    Falade-Nwulia, Oluwaseun
    Irvin, Risha
    Merkow, Alana
    Sulkowski, Mark
    Niculescu, Alexander
    Olsen, Yngvild
    Stoller, Kenneth
    Thomas, David L.
    Latkin, Carl
    Mehta, Shruti H.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 100 : 45 - 51
  • [30] Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in Baltimore, Maryland
    Patel, Eshan U.
    Mehta, Shruti H.
    Genberg, Becky L.
    Baker, Owen R.
    Schluth, Catherine G.
    Astemborski, Jacquie
    Fernandez, Reinaldo E.
    Quinn, Thomas C.
    Kirk, Gregory D.
    Laeyendecker, Oliver
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2023, 8